SILTUXIMAB vs SIPONIMOD: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
SILTUXIMAB vs SIPONIMOD: Safety Overview
| Metric | SILTUXIMAB | SIPONIMOD |
|---|---|---|
| Total FAERS Reports | 472 | 8,581 |
| Deaths Reported | 89 | 196 |
| Death Rate | 18.9% | 2.3% |
| Hospitalizations | 145 | 1,396 |
| Average Patient Age | 47.4 yrs | 53.8 yrs |
| % Female Patients | 56.9% | 74.4% |
| FDA Approval Date | N/A | Apr 22, 2025 |
| Manufacturer | Recordati Rare Diseases, Inc. | Novartis Pharmaceuticals Corporation |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Prescription |